Skip to main content
Caplight Logo









FELIQS Corporation

FELIQS Corporation

Private
FukuokaHealthcare & Life Scienceshttps://feliqs.com/

Last Round

Series A

Jul 1, 2025

Total Funding Raised

$12.5M

Company Overview

FELIQS Corporation is a biotechnology company that develops small-molecule therapeutics targeting oxidized lipids and ferroptosis to treat ophthalmological and neonatal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyophthalmologydrug discoverysmall-molecule therapeuticsretinopathy of prematurityROPferroptosislipid peroxidationgeographic atrophyage-related macular degenerationAMDclinical trialsbiotech startuporphan drugdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FELIQS Corporation Comparables

Compare FELIQS Corporation with similar companies based on industry and business-model similarity.

FELIQS Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SeaBeLife
79%
orphanix GmbH
78%
PulseSight Therapeutics
77%

FELIQS Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 1, 2025

Key People

Founding team and executive leadership

ken-ichiro Kuninobu

Co-Founder and CEO

Founding Team

Matt Fowler

Contract CFO

Executive Team

FELIQS Corporation Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    $10M round led by Beyond Next Ventures.

FELIQS Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

FELIQS Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about FELIQS Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersFukuoka
Employee Range7
Year Founded2019
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?